Liposomal doxorubicin (Caelyx‚) in the treatment of recurrent high-grade glioma – a phase I/II study
Liposomal doxorubicin (Caelyx‚) in the treatment of recurrent high-grade glioma – a phase I/II study. Proceedings of the American Society of Clinical Oncology (ASCO) 36. 2000; 36:661.